Telotristat Etiprate Shows Benefit in Treating Patients With Carcinoid Syndrome That is Inadequately Controlled by Somatostatin Analog Therapy in the Phase 3 TELESTAR Clinical Trial Kulke, M. H., Hoersch, D., Caplin, M., Anthony, L., Bergsland, E., Oberg, K., Welin, S., Warner, R., Lombard-Bohas, C., Kunz, P., Grande, E., Valle, J. W., Fleming, D., Lapuerta, P., Banks, P., Jackson, S., Wheeler, D., Zambrowicz, B., Sands, A., Pavel, M. LIPPINCOTT WILLIAMS & WILKINS. 2016: 478

View details for Web of Science ID 000370956600058